Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Exclusive: Therini raises $36M, will target fibrin protein for Alzheimer's and diabetic macular edema
3 years ago
Startups
Evommune raises $50M to fund clinical trials in skin diseases
3 years ago
Startups
With $270M, Beam spinoff Orbital Therapeutics builds RNA medicines as it hunts for partners, more delivery tech
3 years ago
Startups
Cell/Gene Tx
J&J's consumer health spinout Kenvue lines up a $3B+ IPO, biggest health offering since 2018
3 years ago
Pharma
Ideaya goes forward with $150M offering after touting PhII cancer data
3 years ago
R&D
Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD
3 years ago
Startups
PharmaEssentia secures $462M+ to further growth of Besremi and its pipeline
3 years ago
R&D
Chinese biotech startup adds $315M to the bank after bringing 5 Takeda drugs to its fold
3 years ago
China
Abdera raises $110M to push targeted radiotherapies where they haven’t gone before
3 years ago
Legend raises $200M from private investor after conference leaks PhIII Carvykti data
3 years ago
Cell/Gene Tx
Vaxcyte to raise $500M from stock offering for PhIII study of pneumococcal vaccine
3 years ago
Gilde Healthcare bags $657M to fuel 'holistic' search for affordable drugs, technologies
3 years ago
European biotech VC Forbion closes two funds at $1.5B total in its biggest raises to date
3 years ago
VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year
3 years ago
Startups
Cell/Gene Tx
Herceptin founder snags $158M for his UCLA-biotech partnership TORL BioTherapeutics
3 years ago
Startups
After raising $1.15B in just 10 weeks, Lux's Josh Wolfe shares his spending plans for his new VC fund
3 years ago
Deals
Briggs Morrison helms new MPM oncology startup with Pfizer Ventures, Polaris partners on board
3 years ago
Startups
Singaporean cell therapy biotech with off-the-shelf ambitions wraps modest IPO
3 years ago
Acelyrin files to go public in rare sign of biotech IPO
3 years ago
Startups
Keep ‘em coming: Lux Capital bags $1.15B as life sciences funds reel in one round after another in 2023
3 years ago
HSBC is moving to fill a big gap left by SVB's collapse. And they've recruited some familiar faces for the leap
3 years ago
Bioregnum
Updated: Wellington puts a bow on new $476M private biotech fund
3 years ago
CDMO secures $31M Series A to build out Oklahoma manufacturing facility
3 years ago
Manufacturing
Trio of VCs launches Gaelic-inspired Aer Therapeutics with $36M to prove itself in COPD around 2025
3 years ago
Startups
First page
Previous page
34
35
36
37
38
39
40
Next page
Last page